MC
The startup develops a gene therapeutic platform that utilizes ionizable and targeting lipids for the delivery of various gene therapeutics, including mRNA and siRNA. This technology enables healthcare professionals to effectively treat genetic diseases by facilitating precise gene delivery.
Updated 3 months ago
Funding
$2.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a gene therapeutic platform that utilizes ionizable and targeting lipids for the delivery of various gene therapeutics, including mRNA and siRNA. This technology enables healthcare professionals to effectively treat genetic diseases by facilitating precise gene delivery.